Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purine Analog Conditioning for Allogeneic SCT in Severe Aplastic Anemia
NCT00427336Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2000
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in aplastic anemia, sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2000; status: completed.
02
Drugs
fludarabine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT00427336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427336.